News – Page 424 – Endpoints News

Sanofi and Amgen are bringing cash to cover the table stakes for the Horizon M&A game

3 years ago

Updated: FDA remains silent on orphan drug exclusivity after last year's court loss

3 years ago

Federal claims court rules in favor of Gilead in CDC Truvada patent case

3 years ago

Syneos Health predicts pharma trends leaping forward in 2023 after reboot year

3 years ago

As the amoxicillin shortage drags on, several senators pressure FDA and HHS for solutions

3 years ago

Manufacturing roundup: Touchlight nets $2M grant from the Gates Foundation; Experic closes $14M Series B

3 years ago

ViiV drives new corporate coalition including Uber, Tinder and Walmart, aimed at ending HIV

3 years ago

Pfizer will invest $1.2B+ in Irish manufacturing site, adding 500 employees

3 years ago

ICER rates Astellas' potential menopausal symptom drug as promising at about $2K per year

3 years ago

Intellia and Iveric sell stocks to raise money, each netting $300M

3 years ago

Pfizer and Roivant team up again for another 'Vant', setting up anti-inflammatory showdown with Prometheus

3 years ago

As competitors near FDA goalpost, Roche spells out its repeat Alzheimer's setback

3 years ago

FDA approves Rebyota, Ferring's poop-based drug to fight C. diff infection

3 years ago

As money pours into digital therapeutics, insurance coverage crawls

3 years ago

SQZ Biotech slashes headcount by 60% as founder/CEO hits exit — while Synlogic lays off 25%

3 years ago

Rallybio, AbCellera form new partnership around antibodies for rare disease

3 years ago

Eli Lilly’s Alzheimer’s drug clears more amyloid early than Aduhelm in first-ever head-to-head. Will it matter?

3 years ago

Argenx purchases $100M+ FDA priority review voucher from bluebird bio

3 years ago

Lilly's Covid-19 mAb no longer authorized due to Omicron subvariants, FDA says

3 years ago

Twist Bioscience’s 'factory of the future' in Oregon could deliver with competitive pricing, SVB Securities says

3 years ago

Sanofi and DNDi aim to eliminate sleeping sickness in Africa with promising Ph II/III results for new drug

3 years ago

CPI opens the doors to a new $100M+ manufacturing facility in Scotland

3 years ago

Protecting its megablockbuster, Janssen challenges Amgen's Stelara biosimilar ahead of planned 2023 launch

3 years ago

Lexicon slams FDA over hearing denial following a CRL for its SGLT2 inhibitor candidate

3 years ago

First page Previous page 421 422 423424425 426 427 Next page Last page